Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H.
Genitrix, LLC, Cambridge, MA, United States
Search 10 grants from Andrew Segal
Search grants from Genitrix, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of an HIV Prevention Game for African American Rural Adolescents
Methylation-Associated Silencing of Mouse HSP70 Genes
Volumetric Measurement of Human Calf Muscle From MRI
Regurgitant Orifice Area in Aortic Regurgitation
Analytical Core
Recently added grants:
Targeting Nicotinamide Adenine Dinucleotide (NAD+) metabolism in IDH mutant gliomas
Shared Resource-Flow Cytometry Core
Shared Resource-Functional Genomics and Genome Sequencing Core
Endothelial cells regulate immune reconstitution after hematopoietic stem cell transplantation
Shared Resource-Mass Spectrometry Core-Proteomics and Metabolomics
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
3R43CA074665-01A1S1
Application #
6021665
Study Section
Special Emphasis Panel (ZRG2 (02))
Program Officer
Reynolds, Craig W
Project Start
1997-09-30
Project End
1999-06-30
Budget Start
1997-09-30
Budget End
1999-06-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Genitrix, LLC
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1999
R43 CA
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H. / Genitrix, LLC
NIH 1997
R43 CA
Development of Tumor Vaccines Using Gpi-Linked Molecules
Segal, Andrew H. / Genitrix, LLC
Comments
Be the first to comment on Andrew Segal's grant